RegenMD - Medtronic, other investors to inject $31.4M into Tengion

RegenMD         Medtronic, other investors to inject $31.4M into Tengion March 1, 2011 at 9:31 PM   Running short of cash, Tengion Inc. has turned to a PIPE transaction to raise money to continue development of its regenerative medicine products. The East Norriton life-sciences firm said that Medtronic Inc., the huge medical device company, ... See all stories on this topic » Philadelphia Inquirer (blog)         World-renowned stem cell researcher to speak March 25 at MSU March 1, 2011 at 5:49 PM   Dr. Irving Weissman, director of the Institute of Stem Cell Biology and Regenerative Medicine at the Stanford University School of Medicine, will speak on "Normal and Neoplastic Stem Cells" at 4 pm Friday, March 25, in the Procrastinator Theater in ... See all stories on this topic » Montana State University         LA BioMed researchers partner with Japanese firm on cell regrowth studies March 1, 2011 at 2:27 PM   "If we can do this here, it would be a major breakthrough in regenerative medicine." Cell sheet engineering involves taking small quantities of a patient's own cells and culturing them in a laboratory. When the cells have grown sufficiently, ... See all stories on this topic »         Surgeons predict the future of nanomedicine in practice March 1, 2011 at 1:00 PM   ... making them useful for drug delivery, or mimic the features of the environment outside cells, making them useful for tissue engineering. ...         CEO of Children's Hospital Oakland appointed to state stem cell agency March 1, 2011 at 11:57 AM   27 to the Independent Citizen's Oversight Committee of the California Institute for Regenerative Medicine. State Controller John Chiang appointed Lubin to the post. Lubin will remain in his position at Children's Hospital Oakland. ... See all stories on this topic »         Regenerative medicine company Tengion raising $31M March 1, 2011 at 10:40 AM   The East Norriton regenerative medicine company said Tuesday that it has entered into definitive agreements with a group of undisclosed investors under which it will sell 11.1 million shares of common stock, and warrants to purchase another 10.5 ... See all stories on this topic »         Regenicin (OTCBB: RGIN) Seeks to Be First-to-Market with Autologous ... March 1, 2011 at 10:40 AM   Regenicin, Inc., a biotechnology company specializing in the development of regenerative cell therapies, is seeking to become the first regenerative medicine company to introduce a commercial product into a multi-billion dollar market. ... See all stories on this topic »         Darpa's 5 Radical Plans for Military Medicine March 1, 2011 at 8:08 AM   So Darpa is looking to use magnetism and electrical fields to build human muscles and tissues, with the Scaffold-Free Tissue Engineering project. ... Wired News         Tengion Announces Pricing of $31.4 Million Private Placement March 1, 2011 at 7:40 AM   EAST NORRITON, Pa., March 1, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that it has entered into definitive agreements with certain investors in connection with a PIPE financing transaction ... See all stories on this topic »         Positive Pre-Clinical Data From Muscle Injury Study Moves Pluristem Toward ... March 1, 2011 at 7:40 AM   The center places emphasis on research and clinical programs related to musculoskeletal, immunological and cardiovascular applications, since these aspects of regenerative medicine are most advanced at the Charite and are closest to clinical ... See all stories on this topic » GlobeNewsWire (press release)         Positive Pre-Clinical Data From Muscle Injury Study Moves Pluristem Toward ... March 1, 2011 at 7:33 AM   The center places emphasis on research and clinical programs related to musculoskeletal, immunological and cardiovascular applications, since these aspects of regenerative medicine are most advanced at the Charite and are closest to clinical ... See all stories on this topic » GlobeNewsWire (press release)         Tengion Announces Pricing of $31.4 Million Private Placement March 1, 2011 at 7:33 AM   EAST NORRITON, Pa., March 1, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that it has entered into definitive agreements with certain investors in connection with a PIPE financing transaction ... See all stories on this topic »             This email was sent to agupta1213+termsc@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here